Connection

Daniel Steinberg to Humans

This is a "connection" page, showing publications Daniel Steinberg has written about Humans.
Connection Strength

0.835
  1. Aortic Diastolic Blood Pressure and Widened Pulse Pressure as Post-Transcatheter Aortic Valve Implantation Measurements. Cardiovasc Revasc Med. 2022 06; 39:26-27.
    View in: PubMed
    Score: 0.031
  2. Examining the Relevance of Chronic Coronary Occlusion in Patients Undergoing TAVR. Cardiovasc Revasc Med. 2020 10; 21(10):1311-1312.
    View in: PubMed
    Score: 0.028
  3. Clinical Evidence and Common Sense in Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2020 05; 21(5):619-620.
    View in: PubMed
    Score: 0.027
  4. Hemodynamic Monitoring During Transcatheter Aortic Valve Replacement - Another Tool in the Shed. Cardiovasc Revasc Med. 2019 04; 20(4):283-284.
    View in: PubMed
    Score: 0.026
  5. Aortic Valve Calcification: Moving Toward the Root of the Problem. J Am Coll Cardiol. 2019 01 29; 73(3):315-316.
    View in: PubMed
    Score: 0.025
  6. Refining indications and access in transcatheter mitral valve-in-valve replacement. Cardiovasc Revasc Med. 2018 Oct - Nov; 19(7 Pt B):814-815.
    View in: PubMed
    Score: 0.025
  7. Continuous Paravertebral Blockade for Post-Thoracotomy Pain Following Transapical Transcatheter Aortic Valve Replacement: A Retrospective Analysis. J Cardiothorac Vasc Anesth. 2017 08; 31(4):e63-e65.
    View in: PubMed
    Score: 0.022
  8. Low-volume contrast medium protocol for comprehensive cardiac and aortoiliac CT assessment in the context of transcatheter aortic valve replacement. Acad Radiol. 2015 Sep; 22(9):1138-46.
    View in: PubMed
    Score: 0.020
  9. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud? in patients with stroke or transient ischemic attack. Catheter Cardiovasc Interv. 2015 Jun; 85(7):1262-7.
    View in: PubMed
    Score: 0.019
  10. Computed tomography imaging of coronary artery plaque: characterization and prognosis. Radiol Clin North Am. 2015 Mar; 53(2):307-15.
    View in: PubMed
    Score: 0.019
  11. Advances in transcatheter valve therapies. J Cardiovasc Transl Res. 2014 Jun; 7(4):375-86.
    View in: PubMed
    Score: 0.018
  12. Transcatheter aortic valve replacement--the initial MUSC experience. J S C Med Assoc. 2013 Dec; 109(4):121-5.
    View in: PubMed
    Score: 0.018
  13. Transradial intervention for unprotected left main PCI--balancing can and should. Cardiovasc Revasc Med. 2013 Jul-Aug; 14(4):191-2.
    View in: PubMed
    Score: 0.017
  14. Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.
    View in: PubMed
    Score: 0.016
  15. Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital. Am J Cardiol. 2012 Apr 15; 109(8):1154-9.
    View in: PubMed
    Score: 0.015
  16. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
    View in: PubMed
    Score: 0.014
  17. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):491-5.
    View in: PubMed
    Score: 0.013
  18. Vulnerable plaque imaging-current techniques. J Cardiovasc Transl Res. 2009 Mar; 2(1):9-18.
    View in: PubMed
    Score: 0.013
  19. Intravascular quantification of coronary calcification - current and future utility. J Invasive Cardiol. 2008 Nov; 20(11):591.
    View in: PubMed
    Score: 0.012
  20. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am J Cardiol. 2008 Jul 15; 102(2):160-4.
    View in: PubMed
    Score: 0.012
  21. Drug-eluting stent thrombosis. Minerva Cardioangiol. 2008 Feb; 56(1):127-37.
    View in: PubMed
    Score: 0.012
  22. Patent foramen ovale closure: past, present and future. Expert Rev Cardiovasc Ther. 2007 Sep; 5(5):881-91.
    View in: PubMed
    Score: 0.011
  23. Snare extraction of a fractured coronary stent in a saphenous vein graft. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):241-3.
    View in: PubMed
    Score: 0.011
  24. Impact of in-stent restenosis on death and myocardial infarction. Am J Cardiol. 2007 Oct 01; 100(7):1109-13.
    View in: PubMed
    Score: 0.011
  25. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol. 2007 Mar 01; 99(5):599-602.
    View in: PubMed
    Score: 0.011
  26. Drug-eluting stent thrombosis vs bare metal stent restenosis: finding the lesser of two evils. Am Heart Hosp J. 2007; 5(3):151-4.
    View in: PubMed
    Score: 0.011
  27. Examining safety and feasibility of intravascular thermographic assessment. J Invasive Cardiol. 2005 Dec; 17(12):667-8.
    View in: PubMed
    Score: 0.010
  28. CT in Transcatheter-delivered Treatment of Valvular Heart Disease. Radiology. 2022 07; 304(1):4-17.
    View in: PubMed
    Score: 0.008
  29. Native Coronary Artery Pseudoaneurysm after Coronary Artery Bypass Grafting. Heart Surg Forum. 2022 Apr 22; 25(2):E297-E299.
    View in: PubMed
    Score: 0.008
  30. Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility Study. Circ Heart Fail. 2022 02; 15(2):e008934.
    View in: PubMed
    Score: 0.008
  31. Coronary CT Fractional Flow Reserve before Transcatheter Aortic Valve Replacement: Clinical Outcomes. Radiology. 2022 01; 302(1):50-58.
    View in: PubMed
    Score: 0.008
  32. Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study. Circ Heart Fail. 2020 11; 13(11):e007981.
    View in: PubMed
    Score: 0.007
  33. Hemodynamic Impact of MitraClip Procedure for Systemic Tricuspid Regurgitation in Congenitally Corrected Transposition of Great Arteries: A Case Report. Cardiovasc Revasc Med. 2021 07; 28S:114-117.
    View in: PubMed
    Score: 0.007
  34. SCAI expert consensus statement update on best practices for transradial angiography and intervention. Catheter Cardiovasc Interv. 2020 02; 95(2):245-252.
    View in: PubMed
    Score: 0.007
  35. Influence of Coronary Calcium on Diagnostic Performance of Machine Learning CT-FFR: Results From MACHINE Registry. JACC Cardiovasc Imaging. 2020 03; 13(3):760-770.
    View in: PubMed
    Score: 0.007
  36. Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure. Am J Cardiol. 2019 09 01; 124(5):756-762.
    View in: PubMed
    Score: 0.006
  37. Effects of Percutaneous LVAD Support on Right Ventricular Load and Adaptation. J Cardiovasc Transl Res. 2019 04; 12(2):142-149.
    View in: PubMed
    Score: 0.006
  38. Coronary CT Angiography-derived Fractional Flow Reserve: Machine Learning Algorithm versus Computational Fluid Dynamics Modeling. Radiology. 2018 Jul; 288(1):64-72.
    View in: PubMed
    Score: 0.006
  39. Coronary CT Angiography-derived Fractional Flow Reserve. Radiology. 2017 10; 285(1):17-33.
    View in: PubMed
    Score: 0.006
  40. Coronary Computed Tomographic Angiography-Derived Fractional Flow Reserve for Therapeutic Decision Making. Am J Cardiol. 2017 Dec 15; 120(12):2121-2127.
    View in: PubMed
    Score: 0.006
  41. Coronary Computed Tomographic Angiography-Derived Fractional Flow Reserve Based on Machine Learning for Risk Stratification of Non-Culprit Coronary Narrowings in Patients with Acute Coronary Syndrome. Am J Cardiol. 2017 Oct 15; 120(8):1260-1266.
    View in: PubMed
    Score: 0.006
  42. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications. Pharmacotherapy. 2017 Apr; 37(4):393-400.
    View in: PubMed
    Score: 0.006
  43. CT angiography for planning transcatheter aortic valve replacement using automated tube voltage selection: Image quality and radiation exposure. Eur J Radiol. 2017 Jan; 86:276-283.
    View in: PubMed
    Score: 0.005
  44. Correlation and predictive value of aortic root calcification markers with coronary artery calcification and obstructive coronary artery disease. Radiol Med. 2017 Feb; 122(2):113-120.
    View in: PubMed
    Score: 0.005
  45. Diagnostic accuracy of coronary CT angiography using 3rd-generation dual-source CT and automated tube voltage selection: Clinical application in a non-obese and obese patient population. Eur Radiol. 2017 Jun; 27(6):2298-2308.
    View in: PubMed
    Score: 0.005
  46. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis. J Cardiovasc Comput Tomogr. 2016 Sep-Oct; 10(5):377-83.
    View in: PubMed
    Score: 0.005
  47. Coronary CT angiography derived morphological and functional quantitative plaque markers correlated with invasive fractional flow reserve for detecting hemodynamically significant stenosis. J Cardiovasc Comput Tomogr. 2016 May-Jun; 10(3):199-206.
    View in: PubMed
    Score: 0.005
  48. Vascular Imaging Before Transcatheter Aortic Valve Replacement (TAVR): Why and How? Curr Cardiol Rep. 2016 Feb; 18(2):14.
    View in: PubMed
    Score: 0.005
  49. Transcatheter Aortic Valve Replacement: Imaging Techniques for Aortic Root Sizing. J Thorac Imaging. 2015 Nov; 30(6):349-58.
    View in: PubMed
    Score: 0.005
  50. Comparison of quantitative stenosis characteristics at routine coronary computed tomography angiography with invasive fractional flow reserve for assessing lesion-specific ischemia. J Cardiovasc Comput Tomogr. 2015 Nov-Dec; 9(6):546-52.
    View in: PubMed
    Score: 0.005
  51. A non-contrast self-navigated 3-dimensional MR technique for aortic root and vascular access route assessment in the context of transcatheter aortic valve replacement: proof of concept. Eur Radiol. 2016 Apr; 26(4):951-8.
    View in: PubMed
    Score: 0.005
  52. Diagnostic value of quantitative stenosis predictors with coronary CT angiography compared to invasive fractional flow reserve. Eur J Radiol. 2015 Aug; 84(8):1509-1515.
    View in: PubMed
    Score: 0.005
  53. Coronary CT angiography-derived fractional flow reserve correlated with invasive fractional flow reserve measurements--initial experience with a novel physician-driven algorithm. Eur Radiol. 2015 Apr; 25(4):1201-7.
    View in: PubMed
    Score: 0.005
  54. Dual-source CT imaging to plan transcatheter aortic valve replacement: accuracy for diagnosis of obstructive coronary artery disease. Radiology. 2015 Apr; 275(1):80-8.
    View in: PubMed
    Score: 0.005
  55. Comparison of diagnostic value of a novel noninvasive coronary computed tomography angiography method versus standard coronary angiography for assessing fractional flow reserve. Am J Cardiol. 2014 Nov 01; 114(9):1303-8.
    View in: PubMed
    Score: 0.005
  56. Tools and techniques--clinical: paravalvular leak closure. EuroIntervention. 2014 Mar 20; 9(11):1359-63.
    View in: PubMed
    Score: 0.004
  57. Functioning Cooley-Cutter aortic valve prosthesis 40 years after implantation. J Thorac Cardiovasc Surg. 2014 Mar; 147(3):e21-2.
    View in: PubMed
    Score: 0.004
  58. Left ventricular end-diastolic pressure affects measurement of fractional flow reserve. Cardiovasc Revasc Med. 2013 Jul-Aug; 14(4):218-22.
    View in: PubMed
    Score: 0.004
  59. Recurrent events after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):541-6.
    View in: PubMed
    Score: 0.004
  60. Comparison of lipid deposition at coronary bifurcations versus at nonbifurcation portions of coronary arteries as determined by near-infrared spectroscopy. Am J Cardiol. 2013 Aug 01; 112(3):369-72.
    View in: PubMed
    Score: 0.004
  61. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):838-45.
    View in: PubMed
    Score: 0.004
  62. Percutaneous mitral valve repair with the MitraClip? system under deep sedation and local anaesthesia. EuroIntervention. 2012 Sep; 8(5):587-90.
    View in: PubMed
    Score: 0.004
  63. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv. 2013 Feb; 81(2):335-9.
    View in: PubMed
    Score: 0.004
  64. Coronary CT angiography versus conventional cardiac angiography for therapeutic decision making in patients with high likelihood of coronary artery disease. Radiology. 2012 Nov; 265(2):385-92.
    View in: PubMed
    Score: 0.004
  65. Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). Am J Cardiol. 2012 Oct 15; 110(8):1119-24.
    View in: PubMed
    Score: 0.004
  66. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv. 2013 Feb; 81(2):348-55.
    View in: PubMed
    Score: 0.004
  67. Percutaneous approaches to mitral valve regurgitation. Herz. 2012 Mar; 37(2):172-82.
    View in: PubMed
    Score: 0.004
  68. Multimodality direct coronary imaging with combined near-infrared spectroscopy and intravascular ultrasound: initial US experience. Catheter Cardiovasc Interv. 2013 Feb; 81(3):551-7.
    View in: PubMed
    Score: 0.004
  69. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):429-37.
    View in: PubMed
    Score: 0.004
  70. How should I treat a misplaced self-expanding aortic bioprosthetic valve? EuroIntervention. 2010 Sep; 6(4):537-42.
    View in: PubMed
    Score: 0.004
  71. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J. 2010 May; 31(9):1079-87.
    View in: PubMed
    Score: 0.003
  72. Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography. JACC Cardiovasc Imaging. 2009 Dec; 2(12):1404-11.
    View in: PubMed
    Score: 0.003
  73. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv. 2009 Nov 15; 74(6):889-95.
    View in: PubMed
    Score: 0.003
  74. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Revasc Med. 2009 Jul-Sep; 10(3):156-61.
    View in: PubMed
    Score: 0.003
  75. Can acute occlusion of the left anterior descending coronary artery produce a typical "takotsubo" left ventricular contraction pattern? Am J Cardiol. 2009 Jul 15; 104(2):202-4.
    View in: PubMed
    Score: 0.003
  76. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):866-70.
    View in: PubMed
    Score: 0.003
  77. Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions. Am Heart J. 2009 May; 157(5):894-8.
    View in: PubMed
    Score: 0.003
  78. Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol. 2009 May; 21(5):210-4.
    View in: PubMed
    Score: 0.003
  79. Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv. 2009 Apr 01; 73(5):612-7.
    View in: PubMed
    Score: 0.003
  80. Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era. Am J Cardiol. 2009 Apr 01; 103(7):950-3.
    View in: PubMed
    Score: 0.003
  81. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
    View in: PubMed
    Score: 0.003
  82. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Am J Cardiol. 2009 Feb 15; 103(4):496-500.
    View in: PubMed
    Score: 0.003
  83. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009 Feb; 102(2):143-51.
    View in: PubMed
    Score: 0.003
  84. Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
    View in: PubMed
    Score: 0.003
  85. Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention. J Interv Cardiol. 2009 Feb; 22(1):61-7.
    View in: PubMed
    Score: 0.003
  86. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009 Mar 15; 103(6):801-5.
    View in: PubMed
    Score: 0.003
  87. Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2009 Mar 01; 103(5):653-8.
    View in: PubMed
    Score: 0.003
  88. The predictive value of computed tomography calcium scores: a comparison with quantitative volumetric intravascular ultrasound. Cardiovasc Revasc Med. 2009 Jan-Mar; 10(1):30-5.
    View in: PubMed
    Score: 0.003
  89. Interventional treatment of structural heart disease. Minim Invasive Ther Allied Technol. 2009; 18(3):110-21.
    View in: PubMed
    Score: 0.003
  90. Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events. J Invasive Cardiol. 2008 Dec; 20(12):635-9.
    View in: PubMed
    Score: 0.003
  91. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):799-803.
    View in: PubMed
    Score: 0.003
  92. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol. 2008 Dec 15; 102(12):1614-7.
    View in: PubMed
    Score: 0.003
  93. Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Nov 15; 102(10):1318-22.
    View in: PubMed
    Score: 0.003
  94. Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions. Am J Cardiol. 2008 Nov 01; 102(9):1175-81.
    View in: PubMed
    Score: 0.003
  95. Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings. Am J Cardiol. 2008 Oct 15; 102(8):994-1001.
    View in: PubMed
    Score: 0.003
  96. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008 Sep 01; 102(5):530-4.
    View in: PubMed
    Score: 0.003
  97. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol. 2008 Sep 01; 102(5):535-40.
    View in: PubMed
    Score: 0.003
  98. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern. Am J Cardiol. 2008 Sep 01; 102(5):621-4.
    View in: PubMed
    Score: 0.003
  99. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
    View in: PubMed
    Score: 0.003
  100. Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock. Am J Cardiol. 2008 Aug 01; 102(3):287-91.
    View in: PubMed
    Score: 0.003
  101. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol. 2008 Aug 01; 102(3):298-303.
    View in: PubMed
    Score: 0.003
  102. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Am J Cardiol. 2008 Aug 01; 102(3):292-7.
    View in: PubMed
    Score: 0.003
  103. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008 Jun 01; 101(11):1544-9.
    View in: PubMed
    Score: 0.003
  104. Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus. Am J Cardiol. 2008 May 01; 101(9):1253-8.
    View in: PubMed
    Score: 0.003
  105. Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. Am J Cardiol. 2008 Feb 15; 101(4):452-6.
    View in: PubMed
    Score: 0.003
  106. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
    View in: PubMed
    Score: 0.003
  107. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Feb 01; 101(3):293-9.
    View in: PubMed
    Score: 0.003
  108. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome? Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):826-31.
    View in: PubMed
    Score: 0.003
  109. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol. 2007 Oct; 20(5):307-13.
    View in: PubMed
    Score: 0.003
  110. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007 Sep 11; 116(11 Suppl):I200-6.
    View in: PubMed
    Score: 0.003
  111. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation. 2007 Aug 07; 116(6):677-82.
    View in: PubMed
    Score: 0.003
  112. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):167-72.
    View in: PubMed
    Score: 0.003
  113. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. Am J Cardiol. 2007 Sep 15; 100(6):965-9.
    View in: PubMed
    Score: 0.003
  114. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007 Jul 01; 70(1):9-14.
    View in: PubMed
    Score: 0.003
  115. Assessing risk after acute myocardial infarction. J Am Coll Cardiol. 2007 Jun 05; 49(22):2227; author reply 2227-8.
    View in: PubMed
    Score: 0.003
  116. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv. 2006 Dec; 68(6):873-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.